A landmark UK trial aiming to revolutionise prostate cancer screening has begun testing its first male participants. The ...

A prostate cancer screening trial will make recruiting black men a priority because they face double the risk of getting the ...

CAMBRIDGE, England--(BUSINESS WIRE)--Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis of the disease and accelerate ...

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast ...

A scan that makes prostate cancer cells “glow” could halve the number of men needing invasive biopsies, research suggests.

Prostate cancer is the most common form of cancer among men in England, with cases surging by 25 per cent between 2019 and 2023, according to NHS data. It’s also the second-deadliest form of the ...

There is both good news and bad news about prostate cancer screening. First, the bad news: the blood test involved, which measures a compound called prostate-specific antigen (PSA), is too inaccurate.

International experts have recommended quick and targeted MRI scans for prostate cancer screening. Some 21 urologists, radiologists and pathologists from Europe and the US agreed an "expert consensus ...

Australian scientists say it could also help reduce the risk of overdiagnosis by determining which cancers are low-risk and will never cause harm.

The first men have taken part in a major UK trial testing new ways to screen for prostate cancer and detect the disease earlier ...